A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding

As SARS-CoV-2 continues to spread around the world, there is an urgent need for new assay formats to characterize the humoral response to infection. Convalescent serum is being used for treatment and for isolation of patient-derived antibodies. However, currently there is not a simple means to estim...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:medRxiv
Auteurs principaux: Byrnes, James R., Zhou, Xin X., Lui, Irene, Elledge, Susanna K., Glasgow, Jeff E., Lim, Shion A., Loudermilk, Rita, Chiu, Charles Y., Wilson, Michael R., Leung, Kevin K., Wells, James A.
Format: Artigo
Langue:Inglês
Publié: Cold Spring Harbor Laboratory 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273274/
https://ncbi.nlm.nih.gov/pubmed/32511506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.27.20114652
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires